VOLUME 49 | NUMBER 4 | AUGUST 2014
Incident User Cohorts for Assessing Medication Cost-Offsets
Keywords: Drug initiator design;statins;cost-offsets.
Objective: To develop and test incident drug user designs for assessing cost savings from statin use in diabetics.
Data Source: Random 5 percent sample of Medicare beneficiaries, 2006–2008.
Study Design: Seven-step incident user design to assess impact of statin initiation on subsequent Medicare spending: (1) unadjusted pre/post initiation test; (2) unadjusted difference-in-difference (DID) with comparison series; (3) adjusted DID; (4) propensity score (PS)-matched DID with static and dynamic baseline covariates; (5) PS-matched DID by drug adherence strata; (6) PS-matched DID for high adherers controlling for healthy adherer bias; and (7) replication for ACE-inhibitor/ARB initiators.
Data Collection/Extraction Methods: Subjects with prevalent diabetes and no statin use (January–June 2006) and statin initiation (July 2006–January 2008) compared to nonusers with a random “potential-initiation” month. Monthly Medicare spending tracked 24 months pre- and post-initiation.
Principal Findings: Statistically significant savings in Medicare spending were observed beginning 7 months post-initiation for statins and 13 months post-initiation for ACEIs/ARBs. However, these savings were only observed for adherent patients in steps 5 and 6.
Conclusions: Drug initiator designs are more robust to confounding than prevalent user designs in assessing cost-offsets from drug use but still require other adjustments and sensitivity analysis to ensure proper inference.
Copyright© 2017, Health Research & Educational Trust. All rights reserved. Content Disclaimer
Health Research & Educational Trust, 155 North Wacker, 4th Floor Chicago, IL 60606 (312) 422.2600